International Biotechnology Trust’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$3.25M Sell
28,877
-40,000
-58% -$4.5M 1.09% 26
2023
Q2
$6.49M Buy
+68,877
New +$6.49M 1.98% 18
2022
Q4
Sell
-30,000
Closed -$3.19M 68
2022
Q3
$3.19M Buy
30,000
+6,992
+30% +$742K 1.02% 29
2022
Q2
$236K Sell
23,008
-179,992
-89% -$1.85M 2.46% 16
2022
Q1
$3.15M Sell
203,000
-77,000
-28% -$1.19M 0.71% 35
2021
Q4
$23.8M Sell
280,000
-9,500
-3% -$809K 5.31% 2
2021
Q3
$27.7M Buy
289,500
+82,500
+40% +$7.91M 6.69% 2
2021
Q2
$20.1M Hold
207,000
5.31% 6
2021
Q1
$20.1M Buy
207,000
+183,000
+763% +$17.8M 5.32% 4
2020
Q4
$2.3M Sell
24,000
-197,800
-89% -$18.9M 0.63% 30
2020
Q3
$21.3M Buy
221,800
+116,000
+110% +$11.2M 6.89% 2
2020
Q2
$13.3M Sell
105,800
-1,500
-1% -$188K 4.41% 9
2020
Q1
$9.29M Sell
107,300
-26,000
-20% -$2.25M 4.23% 9
2019
Q4
$14.3M Sell
133,300
-14,000
-10% -$1.5M 5.16% 5
2019
Q3
$13.3M Sell
147,300
-9,500
-6% -$856K 6.13% 4
2019
Q2
$13.2M Buy
156,800
+53,200
+51% +$4.49M 4.91% 3
2019
Q1
$9.13M Sell
103,600
-22,200
-18% -$1.96M 3.37% 7
2018
Q4
$7.05M Buy
125,800
+90,300
+254% +$5.06M 4.38% 8
2018
Q3
$3.35M Sell
35,500
-128,000
-78% -$12.1M 1.59% 23
2018
Q2
$16.1M Buy
163,500
+9,500
+6% +$933K 6.17% 1
2018
Q1
$12.8M Buy
154,000
+117,000
+316% +$9.7M 4.98% 4
2017
Q4
$2.87M Sell
37,000
-29,000
-44% -$2.25M 1.01% 31
2017
Q3
$4.04M Buy
+66,000
New +$4.04M 1.57% 22
2017
Q2
Sell
-40,264
Closed -$1.74M 64
2017
Q1
$1.74M Hold
40,264
0.67% 34
2016
Q4
$1.56M Buy
+40,264
New +$1.56M 0.7% 29